Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration Resistant Prostate Cancer Patients”

638 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 638 results

Not applicableStudy completedNCT04425200
What this trial is testing

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Who this might be right for
Prostatic Neoplasms
AstraZeneca 205
Testing effectiveness (Phase 2)Study completedNCT00271687
What this trial is testing

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisPalliative Care
AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)Ended earlyNCT02146833
What this trial is testing

SHIP (Selinexor in Hormone Insensitive Prostate Cancer)

Who this might be right for
Prostate Cancer
Karyopharm Therapeutics Inc 20
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Very early researchNot Yet RecruitingNCT07389187
What this trial is testing

Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
mCRPC
Shanghai Changzheng Hospital 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768255
What this trial is testing

Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Who this might be right for
Abiraterone AcetateMCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye 400
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Ended earlyNCT03137758
What this trial is testing

A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Large-scale testing (Phase 3)Study completedNCT00255606
What this trial is testing

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Tampere University 360
Testing effectiveness (Phase 2)WithdrawnNCT02035124
What this trial is testing

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Who this might be right for
Advanced Prostate Cancer
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)Ended earlyNCT02656615
What this trial is testing

Abiraterone-Rechallenge Study for CRPC Patients

Who this might be right for
Prostate Cancer
Aurelius Omlin 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01560923
What this trial is testing

Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Masonic Cancer Center, University of Minnesota 47
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Early research (Phase 1)Study completedNCT05177042
What this trial is testing

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer Metastatic
Arvinas Androgen Receptor, Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06533644
What this trial is testing

SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syncromune, Inc. 70
Early research (Phase 1)Study completedNCT03835533
What this trial is testing

Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Parker Institute for Cancer Immunotherapy 43
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Looking for participantsNCT07219147
What this trial is testing

177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
City of Hope Medical Center 30
Load More Results